Summary by Moomoo AI
Allarity Therapeutics, Inc. announced that it will be holding its 2024 Annual Meeting of Stockholders on September 3, 2024, at 10:00 a.m. Eastern Time. The meeting will be conducted virtually via live audio webcast. The agenda includes several key proposals, such as the election of two Class II directors, Gerald W. McLaughlin and Laura E. Benjamin, the ratification of Wolf & Company, P.C. as the independent auditor for the fiscal year ending December 31, 2024, and amendments to the company's Certificate of Incorporation to decrease authorized shares and common stock. Additionally, proposals to effect a reverse stock split, approve amendments to the 2021 Equity Incentive Plan, limit the liability of certain officers, and adjourn the meeting if necessary to solicit additional proxies are also on the docket. The board recommends voting FOR all the proposals. The meeting will also address the transaction of other business that may properly come before the Annual Meeting or any continuation, postponement, or adjournment thereof.
